(Q39452315)

12 September 2017

title

A phase I study of paclitaxel and 5-fluorouracil in advanced gastric cancer (English)

1 reference

12 September 2017

1 reference

1 reference

Cascinu S

1

1 reference

12 September 2017

Ficarelli R

2

1 reference

12 September 2017

Safi MA

3

1 reference

12 September 2017

Graziano F

4

1 reference

12 September 2017

Catalano G

5

1 reference

12 September 2017

Cellerino R

6

1 reference

12 September 2017

publication date

1 September 1997

1 reference

European Journal of Cancer

12 September 2017

published in

1 reference

12 September 2017

volume

33

1 reference

12 September 2017

issue

10

1 reference

12 September 2017

page(s)

1699-1702

1 reference

Chemotherapy of gastric cancer

12 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900134-2

7 January 2021

Taxol: a novel investigational antimicrotubule agent

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900134-2

7 January 2021

Paclitaxel-induced apoptosis in human gastric carcinoma cell lines.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900134-2

7 January 2021

Schedule-dependent interaction between paclitaxel and 5-fluorouracil in human carcinoma cell lines in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900134-2

7 January 2021

Reporting results of cancer treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900134-2

7 January 2021

Docetaxel (Taxotere) in advanced gastric cancer: results of a phase II clinical trial. EORTC Early Clinical Trials Group

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900134-2

7 January 2021

European-Canadian randomized trial of paclitaxel in relapsed ovarian cancer: high-dose versus low-dose and long versus short infusion

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900134-2

7 January 2021

Phase I study of paclitaxel (Taxol) and ifosfamide in previously untreated patients with advanced non-small-cell lung cancer. A study of the National Cancer Institute of Canada Clinical Trials Group

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900134-2

7 January 2021

Paclitaxel-induced neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900134-2

7 January 2021

Phase I trial of 3-hour infusion of paclitaxel with or without granulocyte colony-stimulating factor in patients with advanced cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900134-2

7 January 2021

Neuroprotective effect of reduced glutathione on cisplatin-based chemotherapy in advanced gastric cancer: a randomized double-blind placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900134-2

7 January 2021

10.1016/S0959-8049(97)00134-2

Identifiers

DOI

1 reference

12 September 2017

1 reference